186 related articles for article (PubMed ID: 21199872)
1. PIASy inhibits virus-induced and interferon-stimulated transcription through distinct mechanisms.
Kubota T; Matsuoka M; Xu S; Otsuki N; Takeda M; Kato A; Ozato K
J Biol Chem; 2011 Mar; 286(10):8165-8175. PubMed ID: 21199872
[TBL] [Abstract][Full Text] [Related]
2. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
3. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger.
Deng Z; Wan M; Sui G
Mol Cell Biol; 2007 May; 27(10):3780-92. PubMed ID: 17353273
[TBL] [Abstract][Full Text] [Related]
4. PIASy-mediated sumoylation of SREBP1c regulates hepatic lipid metabolism upon fasting signaling.
Lee GY; Jang H; Lee JH; Huh JY; Choi S; Chung J; Kim JB
Mol Cell Biol; 2014 Mar; 34(6):926-38. PubMed ID: 24379443
[TBL] [Abstract][Full Text] [Related]
5. Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.
Yueh A; Leung J; Bhattacharyya S; Perrone LA; de los Santos K; Pu SY; Goff SP
J Virol; 2006 Jan; 80(1):342-52. PubMed ID: 16352559
[TBL] [Abstract][Full Text] [Related]
6. PIASy is a SUMOylation-independent negative regulator of the insulin transactivator MafA.
Onishi S; Kataoka K
J Mol Endocrinol; 2019 Nov; 63(4):297-308. PubMed ID: 31614335
[TBL] [Abstract][Full Text] [Related]
7. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
[TBL] [Abstract][Full Text] [Related]
8. Protein inhibitors of activated STAT (Pias1 and Piasy) differentially regulate pituitary homeobox 2 (PITX2) transcriptional activity.
Wang J; Sun Z; Zhang Z; Saadi I; Wang J; Li X; Gao S; Engle JJ; Kuburas A; Fu X; Yu W; Klein WH; Russo AF; Amendt BA
J Biol Chem; 2013 May; 288(18):12580-95. PubMed ID: 23515314
[TBL] [Abstract][Full Text] [Related]
9. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
Ihara M; Yamamoto H; Kikuchi A
Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
[TBL] [Abstract][Full Text] [Related]
10. PIASy-mediated repression of the androgen receptor is independent of sumoylation.
Gross M; Yang R; Top I; Gasper C; Shuai K
Oncogene; 2004 Apr; 23(17):3059-66. PubMed ID: 14981544
[TBL] [Abstract][Full Text] [Related]
11. Chromatin remodeling: demethylating H3K4me3 of type I IFNs gene by Rbp2 through interacting with Piasy for transcriptional attenuation.
Yu X; Chen H; Zuo C; Jin X; Yin Y; Wang H; Jin M; Ozato K; Xu S
FASEB J; 2018 Feb; 32(2):552-567. PubMed ID: 28970247
[TBL] [Abstract][Full Text] [Related]
12. PIAS1 negatively modulates virus triggered type I IFN signaling by blocking the DNA binding activity of IRF3.
Li R; Pan Y; Shi DD; Zhang Y; Zhang J
Antiviral Res; 2013 Nov; 100(2):546-54. PubMed ID: 24036127
[TBL] [Abstract][Full Text] [Related]
13. Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity.
Martin N; Schwamborn K; Urlaub H; Gan B; Guan JL; Dejean A
Mol Cell Biol; 2008 Apr; 28(8):2771-81. PubMed ID: 18285457
[TBL] [Abstract][Full Text] [Related]
14. MUC1 expression is repressed by protein inhibitor of activated signal transducer and activator of transcription-y.
Brayman MJ; Dharmaraj N; Lagow E; Carson DD
Mol Endocrinol; 2007 Nov; 21(11):2725-37. PubMed ID: 17717071
[TBL] [Abstract][Full Text] [Related]
15. Duck PIAS2 negatively regulates RIG-I mediated IFN-β production by interacting with IRF7.
Zu S; Xue Q; He Z; Shi C; Wu W; Zhang J; Li W; Huang J; Jiao P; Liao M
Dev Comp Immunol; 2020 Jul; 108():103664. PubMed ID: 32151676
[TBL] [Abstract][Full Text] [Related]
16. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
Subramanian L; Benson MD; Iñiguez-Lluhí JA
J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
[TBL] [Abstract][Full Text] [Related]
17. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis.
Bischof O; Schwamborn K; Martin N; Werner A; Sustmann C; Grosschedl R; Dejean A
Mol Cell; 2006 Jun; 22(6):783-794. PubMed ID: 16793547
[TBL] [Abstract][Full Text] [Related]
18. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
[TBL] [Abstract][Full Text] [Related]
19. Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.
Conn KL; Wasson P; McFarlane S; Tong L; Brown JR; Grant KG; Domingues P; Boutell C
J Virol; 2016 May; 90(9):4807-4826. PubMed ID: 26937035
[TBL] [Abstract][Full Text] [Related]
20. Distinct functional modes of SUMOylation for retinoid X receptor alpha.
Lee WP; Jena S; Rodriguez EP; O'Donovan SP; Wagner C; Jurutka PW; Thompson PD
Biochem Biophys Res Commun; 2015 Aug; 464(1):195-200. PubMed ID: 26116533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
